1. Introduction {#s0005}
===============

Since many decades environmental pollution pertaining to the tremendous application of organophosphorus (OPs) insecticides have been a serious issue. The widespread involvement of OPs in several commodities led their residual appearance in food, drinking water and environment ([@b0080]). Alone in 2014, the global consumption of active ingredients containing OPs insecticides reached to 29972.53 tonnes ([@b0205]). The persistent and bio-accumulative properties of pesticides classify them as an environmental contaminant and precursor of diverse human health ailments. Great concern has been made towards the cholinergic effects of OPs insecticides. The OPs insecticides preferentially bind to impair the functionality of acetylcholinesterase. Perpetual signalling of neurons triggers cell death by asphyxiation has been observed due to acetylcholinesterase inhibition ([@b0045]). OPs insecticides encompass the thiophosphoryl bond (P000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000S) or phosphoryl bond (PO) moiety. Metabolites of OPs insecticides harboring these groups have been attributed as potent genotoxicants ([@b0050], [@b0195]).

Phorate is a class I extremely toxic insecticide, critically known for its anti-acetylcholinesterase activity by the accumulation of acetylcholine, which hampers the synaptic transmission in neuronal cholinergic areas ([@b0005]). Phorate oxon, a metabolite of phorate has been recently found to inhibit the acetylcholinesterase activity of human, guinea pig and rat ([@b0115]). Phorate has been detected in several food commodities above than the limit values ([@b0190], [@b0200], [@b0120]). Workers engaged in the formulation of phorate showed inhibition of testosterone metabolism, sister chromatid exchange, chromosomal aberrations, and DNA damage ([@b0020], [@b0070], [@b0185]). Phorate reported to induced cytogenetic changes, alters mitochondrial membrane functionality (Δ*Ψm*) and ROS generation in different test systems ([@b0165], [@b0065], [@b0090], [@b0100], [@b0025], [@b0140], [@b0150]). Earlier, we have demonstrated that phorate exposed rats exhibited cyto-genotoxic anomalies and cell death via induction of caspases and *p53* genes ([@b0145]). Nonetheless, it is hard to find any report addressing the interaction mechanism of phorate-DNA, and its genotoxic potential in human cells. Hence, we aimed to study the phorate treated human lymphocytes for (i) oxidative stress (ii) dysfunction of Δ*Ψm* (iii) cytogenetic and genotoxic responses (iv) quantifying 8-oxodG adduct formation and strand breaks in DNA.

2. Materials and methods {#s0010}
========================

2.1. Comet assay {#s0015}
----------------

DNA damage was quantitated following the previous method ([@b0135]). Lymphocytes were isolated using histopaque from the whole blood of a healthy male donor having no history of the following habits *viz.* alcohol, tobacco, medication and heavy physical activity. Lymphocytes were suspended in 1 ml of RPMI-1640 containing phorate (10, 100, 250, 500, 750, 1000 µM). The treated cells were kept in a CO~2~ incubator (5%) for 3 h at 37 °C. Comet slides were prepared in low melting (0.5%) and normal melting agarose (1%). Lysis was done for overnight followed by the unwinding and electrophoresis (buffer pH \> 13) of cells at 24 V (300 mA) for 30 min. All slides were then subjected to neutralization, staining of cells were done with 20 µg/ml of ethidium bromide. DNA damage was analyzed on a fluorescence microscope (Nikon Eclips 80i, Japan) equipped with software (Comet Assay IV, Perceptive Instruments, Suffolk, UK).

2.2. CBMN assay {#s0020}
---------------

Phorate induced CBMN formation was quantified in whole blood as explained earlier ([@b0135]). Blood (0.5 ml) were treated with phorate (50, 100 and 200 µM) for 24 h and incubated at 37 °C in CO~2~ (5%) incubator. Furthermore, blood was pelleted at 1000 rpm, washed and resuspended in RPMI-1640 media without phorate. After the completion of 44 h of culture, cyto B (6 µg/ml) was added and continued for incubation till 72 h. Blood was finally pelleted by centrifugation (1000 rpm, 10 min) with subsequent treatment of cells with hypotonic solution (KCl 0.56%) and fixed with glacial acetic acid:methanol (1:3) for 24 h at 4 °C, followed by slide preparation. Staining was done separately with 6 µg/ml propiodium iodide and 6% Giemsa stain in PBS. Micronuclei counting was done from 1000 binucleated cells following the standard criteria ([@b0015]). To determine the nuclear division index (NDI) in treated cells, 500 binucleated cells were separately counted ([@b0135]).

2.3. Quantification of intracellular ROS {#s0025}
----------------------------------------

Phorate induced ROS generation was quantitated using fluorescence spectroscopy following our previous method ([@b0135]). 2 × 10^6^ lymphocytes were exposed to phorate (50, 100, 250 and 500 µM) and incubated (5% CO~2~) at 37 °C for 24 h. After incubation, cells were centrifuged and pellets were resuspended in saline buffer (2 ml), followed by staining with DCFH-DA (5 µM) at 37 °C. After 1 h of staining, washing was done and pellets were resuspended in 3 ml of PBS. Fluorescence of dye was recorded on spectrofluorophotometer (Shimadzu RF5301PC, Japan) at *λ*~ex~ 485 and *λ*~em~ 525 nm.

2.4. Flow cytometric quantitation of mitochondrial membrane potential (ΔΨm) {#s0030}
---------------------------------------------------------------------------

Effect of phorate on Δ*Ψm* of lymphocytes were quantitated following our previous method ([@b0030]). In brief, 2 × 10^6^ lymphocytes were treated for 24 h with 50, 100 and 200 µM of phorate and incubated in CO~2~ (5%) incubator at 37 °C. Cells were centrifuged (3000 rpm, 5 min) followed by resuspension of cells in 500 µl PBS. Cells were stained for 1 h with 5 µg of Rh123 in CO~2~ (5%) incubator, followed by washing with PBS. Fluorescence of 10,000 stained cells were recorded on flow cytometer at FL1-H channel with excitation wavelength of 488 nm (Epics XL/Xl-MCL, Beckman Coulter USA).

2.5. Quantitation of 8-oxodG by ELISA {#s0035}
-------------------------------------

Formation of 8-oxodG in ct-DNA was quantified by following the method as described previously ([@b0030]). ct-DNA in the concentration range of 500, 1000, 1500 and 2000 ng were taken as untreated control. Fixed concentration of phorate (1000 µM) was used to expose the ct-DNA (500, 1000, 1500 and 2000 ng) and mixtures were subjected to white light exposure for 1 h. For positive control, fixed concentration of methylene blue (1000 µM) was used for treating the ct-DNA (500, 1000, 1500 and 2000 ng). After the exposure time, all samples were oven dried in a 96 well plate at 40 °C for 24 h. Blocking of non-specific sites were done for 3 h with BSA (3%) at 37 °C. Samples were incubated with primary antibody (1:100,000) (goat anti 8-hydroxyguanosine) for 2 h. Samples were washed with TMB 1X, followed by incubation with 1:25000 dilution of donkey anti sheep/goat IgG:HRP for 2 h at 37 °C. Reaction was stopped using 2 M H~2~SO~4~, and absorbance was taken at 450 nm using a microplate reader (Labsystems, USA). Commercially available 8-oxodG, as a standard, was used for preparing the calibration curve.

2.6. Alkaline unwinding assay {#s0040}
-----------------------------

Strand breaks in phorate treated ct-DNA was done using hydroxyapatite batch procedure ([@b0135]). ct-DNA (100 µg) was treated with phorate in the molar ratio from 1:2 to 1:10 with or without 100 µM Cu (II). All tubes were incubated for 30 min at 37 °C followed by processing of samples. Elution of ct-DNA (single stranded) from hydroxyapatite matrix was done using 20% formamide in 0.125 M potassium phosphate buffer (pH 7.0). The duplex DNA was removed by 20% formamide in 0.5 M potassium phosphate buffer (pH 7.0). DNA breaks were calculated as described earlier by [@b0135].

3. Results {#s0045}
==========

3.1. Quantitation of DNA damage {#s0050}
-------------------------------

Lymphocytes showed increased DNA damage after treatment with phorate (10--1000 µM) ([Fig. 1](#f0005){ref-type="fig"}). Phorate exposure at 1000 µM showed OTM value of 26.12 ± 1.97 as compared to the OTM of untreated (3.25 ± 0.08) and DMSO (3.72 ± 0.09) controls ([Table 1](#t0005){ref-type="table"}). The extent of DNA damage by phorate at 1000 µM was almost similar to the damage induced by positive control, ethyl methane sulfonate (EMS). Variations in DNA damage in phorate treated cells were observed ([Supplementary Fig. 1](#s0105){ref-type="sec"}). At 250 µM, the values of phorate-treated cells vary from 4 to 16. At this concentration 20% of cells showed OTM of 10. While 500--1000 µM exposure showed OTM \> 20, which gradually enhanced from 7 to 76%. The positive control (EMS) showed 100% cells exhibited OTM \> 20, comparatively 91% of control cells were having OTM of 4.Fig. 1Epi-fluorescence comet images of phorate showing DNA damage in human lymphocytes after 3 h of exposure.Table 1Phorate-induced DNA damage in human lymphocytes analyzed using different parameters of comet assay.GroupsOlive tail moment (Arbitrary Unit)Tail DNA (%)Tail length (µm)Control3.25 ± 0.087.08 ± 0.1757.61 ± 3.85DMSO (0.5%)3.72 ± 0.099.27 ± 0.3063.03 ± 5.19EMS (2 mM)30.52 ± 3.48^\*\*\*^38.63 ± 1.95^\*\*\*^187.57 ± 12.70^\*\*\*^Phorate (µM)104.07 ± 0.1610.03 ± 0.5474.72 ± 9.951005.89 ± 0.4412.58 ± 0.55^\*\*^123.19 ± 16.16^\*\*^2509.21 ± 1.43\*16.46 ± 1.00^\*\*\*^163.36 ± 29.93^\*\*\*^50012.58 ± 2.23^\*\*^19.73 ± 2.08^\*\*\*^191.86 ± 11.71^\*\*\*^75018.30 ± 1.99^\*\*\*^23.03 ± 1.05^\*\*\*^238.08 ± 19.66^\*\*\*^100026.12 ± 1.97^\*\*\*^28.13 ± 0.76^\*\*\*^261.84 ± 17.98^\*\*\*^[^1]

3.2. BNMN formation in lymphocytes {#s0055}
----------------------------------

An enhancement in BNMN formation was found after phorate treatment. The representative images of phorate treated lymphocytes clearly show the presence of micronucleus, while the controls showed typical binucleated cells without micronuclei ([Fig. 2](#f0010){ref-type="fig"}). Average BNMN at 50, 100 and 200 µM of phorate were found 11, 16.5 and 26.5. Comparatively, the untreated control, solvent control and positive control exhibited 4.1, 5.0 and 15.3 BNMN cells. The NDI value determined for the phorate (50, 100 and 200 µM) treated groups were 1.92, 1.89 and 1.80, relatively the untreated control showed NDI of 1.94 ([Table 2](#t0010){ref-type="table"}).Fig. 2Representative photomicrographs of the typical binucleated cells showing micronuclei in phorate treated lymphocytes after 24 h of exposure. Cells appearing light blue were stained with 6% Giemsa stain and light pink are the fluorescence of propiodium iodide (6 µg/ml) stained cells belong to the same set of treatments. Arrow indicate the presence of micronuclei in phorate and positive control (MMS) treated cells.Table 2Effect of phorate on micronuclei formation in human lymphocytes.CompoundDoseBNMN/1000 cellsNDIControl04.1 ± 1.711.94DMSO Control1.2%5.0 ± 1.581.95MMS (µM)10015.3 ± 2.97\*1.82Phorate (µM)5011.0 ± 1.4119210016.5 ± 3.53\*1.8920026.50 ± 2.12\*1.80[^2]

3.3. Intracellular ROS generation by phorate {#s0060}
--------------------------------------------

Human lymphocytes cultured with phorate for 24 h showed enhancement in the fluorescence emission spectra of DCFH-DA stained cells ([Fig. 3](#f0015){ref-type="fig"}A). Comparative to control, phorate exposed cells showed significant increase in the oxidation of DCFH-DA dye to DCF. Cells treated with phorate in the range of 50--500 µM showed 17% to 60.43% higher fluorescence intensity of DCF. H~2~O~2~ (400 µM) showed 19% and 1% DMSO showed 3.11% increase in DCF fluorescence ([Fig. 3](#f0015){ref-type="fig"}B).Fig. 3Intracellular quantitation of ROS by fluorescence spectrophotometer. (A) Emission spectra showing enhanced fluorescence of DCF in lymphocytes treated with varying concentrations of phorate. From bottom to top, spectrum 1: untreated control, spectrum 2: DMSO (1%) solvent control, spectrum 3: phorate 50 µM, spectrum 4: H~2~O~2~ (400 µM) as positive control, spectra (5, 6 and 7): phorate 100, 250 and 500 µM. (B) The corresponding plot of DCF fluorescence relative to untreated control. Each histogram is the mean ± S.D of three independent experiments. Ct1; untreated control, Ct2; DMSO (1%) solvent control, Ct3; H~2~O~2~ (400 µM) as positive control. \**p \< 0.05* vs DMSO control.

3.4. Effect of phorate on Δψm {#s0065}
-----------------------------

Flow cytometric analysis of phorate treated and untreated human lymphocytes exhibited distinctive variations in the fluorescence of Rh123 stained cells ([Fig. 4](#f0020){ref-type="fig"}A). Compared to the untreated control, human lymphocytes treated with phorate (50, 100 and 200 µM) for 24 h significantly perturbed the functionality of mitochondria, manifested as reduction in Rh123 fluorescence from 71.18%, 75.65% and 81.77%, respectively ([Fig. 4](#f0020){ref-type="fig"}B).Fig. 4Phorate induce dysfunction of mitochondrial membrane potential (Δ*Ψm*) in human lymphocytes. (A) Representative flow cytometric image showing Rh123 fluorescence in human lymphocytes treated with phorate. MFI: mean fluorescence intensity. (B) Histograms showing Rh123 fluorescence in phorate treated human lymphocytes. Each histogram is the mean ± S.D of Rh123 fluorescence obtained in three independent experiments (*\*p \< 0.05* relative to control). Ct 1: untreated control.

3.5. 8-oxodG formation in phorate treated ct-DNA {#s0070}
------------------------------------------------

Exposure of ct-DNA with phorate resulted in 8-oxodG adduct formation. Compared to control, ct-DNA at the concentrations of 500, 1000, 1500 and 2000 ng treated to a fixed concentration of phorate (1000 µM) induced 1.3, 1.8, 2.1 and 2.3-fold higher 8-oxodG adduct formation. The frequency of 8-oxodG formation by phorate was higher than the positive control. Under the similar condition, ct-DNA (500, 1000, 1500 and 2000 ng) exposed to positive control (methylene blue, 1000 µM) showed 1.2, 1.6, 1.7, 1.6-fold 8-oxodG adduct formation ([Supplementary Fig. 2](#s0105){ref-type="sec"}).

3.6. DNA breaks after phorate exposure {#s0075}
--------------------------------------

Selective elution of broken DNA using hydroxyapatite matrix showed enhancement in the single stranded DNA with simultaneous reduction in duplex DNA upon phorate and phorate-Cu (II) treatment ([Supplementary Fig. 3](#s0105){ref-type="sec"}). At the highest DNA nucleotide/phorate molar ratio (1:10) plus 100 µM Cu (II), almost equal number of strand breaks were quantitated as obtained with EMS. Strand breaks (n) determined for phorate alone and phorate-Cu (II) exposed DNA were; 1.0, 1.5, 2.2, 2.8, 4.0 and 1.6, 2.8, 3.7, 4.6, 6.5 at DNA nucleotide/phorate molar ratio of 1:2, 1:4, 1:6, 1:8 and 1:10, respectively. The negative control (untreated ct-DNA) did not show any strand breaks. Treatment with EMS (2 mM) taken as positive control has induced 7.0 breaks/unit of DNA ([Supplementary Table 1](#s0105){ref-type="sec"}).

4. Discussion {#s0080}
=============

Previously we studied the adverse effects of phorate in rats and WISH cells, as well as demonstrated the conformational alterations in human serum albumin ([@b0140], [@b0145], [@b0150]). Despite the toxicological consequences of phorate, we encountered a single study demonstrating the lymphocytic toxicity of phorate ([@b0180]). However, a substantial information on the mechanism of genotoxic effects in human cells is still obscure. Herein, we selected human peripheral blood mononuclear cells, as a model to unravel the phorate induced toxicity, manifested in the terms of cytological changes, DNA fragmentation, dysfunction of Δ*Ψm* and oxidative (8-oxodG) DNA adduct formation. A brief exposure (3 h) of human lymphocytes with varying phorate concentrations increased the damage DNA ([Fig. 1](#f0005){ref-type="fig"}). Our comet results are consistent with an earlier finding on phorate induced-DNA damage ([@b0180]). The CBMN assay revealed significant increase in micronuclei formation in human lymphocytes upon phorate treatment, which corroborates well with the micronuclei formation in phorate treated human lymphocytes ([@b0180]) and mice ([@b0165], [@b0025], [@b0180]). An increase in the micronuclei formation strongly suggests that phorate triggered DNA damage, which was beyond the error-free repairing capacity of the cellular machinery in cell cycle ([@b0060]). The appearance of micronuclei in cells are mainly governed by the fragments of acentric chromatid and chromosomes or originate as a consequence of chromosome loss failing which cannot be a part of daughter nuclei and lag behind in cytoplasm during mitosis ([@b0155], [@b0160], [@b0110], [@b0035], [@b0040], [@b0010]). Consequently, micronuclei formation can adversely affect the chromosomal stability in cells. The presence of micronuclei in lymphocytes and its relation with carcinogenesis has been considerably validated in experimental studies ([@b0010]). We have observed a significant reduction in NDI of phorate treated lymphocytes. The lower NDI observed after phorate treatment can be extrapolated with following hypothesis that lymphocytes suffers DNA damage (as evident in comet assay), cannot survive the cell division cycle and enters into necrosis or apoptosis before the end of first division. Also, there may be a mitotic delay, hampering the rectification of strand-breaks, such situations inhibit cellular gateway to mitosis, and affect the amount of mononuclear, binuclear, trinuclear or tetra-nucleated cells ([@b0075]).

The spectrofluorescence data showed significant enhancement of ROS generation in phorate treated lymphocytes, indicating oxidative stress in cells. Oxidative stress has been categorized as one of the prime factor for severe toxicity in humans exposed to OPs insecticides ([@b0125]). Phorate treated cells also exhibited the alteration of Δ*Ψm*. A noticeable shift in the fluorescence peaks with phorate treatment, along with significant reduction in Rh123 intensity unequivocally suggests the dysfunction of inner mitochondrial membrane, and ROS production ([@b0095], [@b0175]). Changes in inner mitochondrial membrane can lead to increase in the permeability of its external membrane, which liberate the mitochondrial-apoptogenic factors in cytoplasm ([@b0085]). In addition, distraction of Δ*Ψm* frequently leads to degradation of nuclear DNA ([@b0105]).

Production of ROS upon phorate treatment unequivocally indicate the induction of oxidative stress in the treated cells. Under oxidative stress more than twenty different types of DNA modifications are formed, including oxidation of sugars, bases and strand breaks. 8-oxodG has received considerable attention due to its mutagenic properties, serve as major oxidative maker. 8-oxodG has been known to induce G → T and G:C → C:G base substitution. The data on phorate induced 8-oxodG formation clearly exhibited higher levels of adduct formation. Considering the genotoxic potential of phorate, we further aimed to quantitated number of breaks in phorate treated ct-DNA. Alkaline unwinding data of phorate and phorate + Cu (II) treatment revealed 4 and 6.5 breaks in ct-DNA (per unit). Involvement of Cu (II) ions in intracellular redox reactions and its affinity for DNA have been extensively studied. The intracellular phorate + Cu (II) and the redox cycling of Cu (II) to Cu (I) along the ct-DNA may also triggers the ROS formation, ultimately resulting in DNA and chromosomal damage, as also evident by the comet and micronuclei data.

5. Conclusion {#s0085}
=============

In conclusion, our data on human lymphocytes exposed to phorate validated its DNA damaging properties in comet assay. CBMN analysis of phorate treated lymphocytes confirm its clastogenic or aneugenic potential, indicating phorate as a cytogenotoxic insecticide. Phorate exposed lymphocytes showed mitochondrial dysfunction. An enhancement in the intracellular ROS unequivocally suggest oxidative stress in phorate treated cells, which preferentially attacks the DNA to increase 8-oxodG adducts and triggers DNA strand breaks. Overall, the data suggest that phorate may also induce similar toxicological consequences in the occupationally or non-occupationally exposed human population. Hence, the application of phorate in various sectors should be given a meticulous attention to avoid human health ailments.
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Appendix A. Supplementary data {#s0105}
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The following are the Supplementary data to this article:Supplementary Fig. 1Effect of phorate concentrations on OTM of DNA comets. Percent distribution of control and phorate-treated lymphocytes is shown based on varying OTM values obtained in phorate concentration range of 10-1000 µM. The untreated (Ct 1), DMSO (1.0%) (Ct 2) and EMS (2 mM) treated cells were taken as negative and positive controls. Each histogram represents the mean value of three independent experiments done in duplicate.

Supplementary Fig. 2ELISA based quantitative analysis of 8-Hydroxy-2\'-deoxyguanosine (8-oxodG) DNA adduct formation in phorate (1 mM) treated ct-DNA for 1h in white light. Methylene blue (MB) 1mM treated ct-DNA were run as positive control. Inset graph show the standard curve of 8-oxodG.

Supplementary Fig. 3Alkaline unwinding of phorate treated ct-DNA. Fraction of duplex DNA recovered after treatment with increasing concentrations of phorate, and plotted as a function of DNA nucleotide/phorate molar ratio. The values plotted are mean ± SEM of two independent experiments done in duplicate.
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[^1]: Data represent the mean ± SEM of three experiments. \**p* \< 0.05; ^\*\*^*p* \< 0.01; ^\*\*\*^*p* \< 0.001; EMS: Ethyl methanesulfonate; DMSO: dimethysulfoxide.

[^2]: MMS: methyl methane sulphonate (as positive control), DMSO: solvent control. \*p \< 0.05, analyzed by Tukey test.
